Keyphrases
Allergic Reaction
100%
Desensitization
100%
Bruton's Tyrosine Kinase
100%
Oxaliplatin
100%
Rapid Drug Desensitization
100%
Acalabrutinib
70%
Anaphylaxis
30%
Basophils
20%
Treatment Regimen
10%
Mechanism of Action
10%
Severe Acute
10%
Locally Advanced
10%
Young Males
10%
Incubation
10%
Twice Daily
10%
Bruton Tyrosine Kinase Inhibitor
10%
Acute Response
10%
CD63
10%
IgE Antibody
10%
Gastrointestinal Cancer
10%
Sensitized Patients
10%
Human IgE
10%
Desensitization Protocol
10%
Skin Prick
10%
Acute Infusion Reaction
10%
Advanced Gastric Carcinoma
10%
Curative Intent Treatment
10%
Basopenia
10%
Medicine and Dentistry
Allergic Response
100%
Desensitization
100%
Oxaliplatin
100%
Bruton Tyrosine Kinase
100%
Acalabrutinib
63%
Anaphylaxis
27%
Basophil
18%
Infusion
9%
In Vitro
9%
Incubation
9%
Immunoglobulin E Antibody
9%
Gastrointestinal Cancer
9%
Stomach Carcinoma
9%
Bruton Tyrosine Kinase Inhibitor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Desensitization
100%
Allergic Reaction
100%
Bruton Tyrosine Kinase
100%
Oxaliplatin
100%
Acalabrutinib
63%
Anaphylaxis
27%
Bruton Tyrosine Kinase Inhibitor
9%
Digestive System Cancer
9%
Immunoglobulin E Antibody
9%
Stomach Carcinoma
9%